Close Menu

NEW YORK (GenomeWeb) – Telegenetics firm Genome Medical has raised $23 million in a series B financing that it will use to nationally scale its services.

Echo Health Ventures led the financing round, with contributions from new investors LRVHelath, Casdin Capital, Perceptive Advisors, Manatt Venture Fund, and Dreamers Fund. Existing investors, including Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures, and HealthInvest Equity Partners, also participated in the round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.